Cargando…
Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
Enhanced understanding of the rheumatoid arthritis (RA) pathophysiology and the role of cytokines has enabled the development of innovative biological agents in the last 10 years that target specific parts of the immune response. Failure to achieve adequate response with traditional disease modifyin...
Autores principales: | Kukar, Manil, Petryna, Olga, Efthimiou, Petros |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763315/ https://www.ncbi.nlm.nih.gov/pubmed/19851470 |
Ejemplares similares
-
Complex Situations in Patients with Adult-Onset Still’s Disease
por: Efthimiou, Petros V., et al.
Publicado: (2011) -
Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients
por: Mehta, Bella, et al.
Publicado: (2015) -
Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2022) -
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019) -
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
por: Hanaoka, Hironari, et al.
Publicado: (2022)